Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-16

Clinical Trial Update: Study to Find Out if Cream V61-044 Used to Treat Fungal Infections Causes an Allergic Skin Reaction to Sunlight in Healthy Participants [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing whether Cream V61-044 for fungal infections causes an allergic skin reaction to sunlight in healthy participants has been completed wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cream V61-044

Snippet

Sponsor: Bayer | Conditions: Dermatitis, Photoallergic | Phase 3 | Status: COMPLETED | Results posted: 2020-11-16